Delivery Order SPE2DB22D2103-SPE2DB25FR8TF

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.33 firm fixed-price delivery order contract is for the supply of FYCOMPA 2 MG TABLET 30S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,913.11, is for the delivery of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,215.11 firm fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,324.16 firm fixed price delivery order is for the supply of Fycompa 8 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.98 delivery order is for the medication FYCOMPA 4 MG TABLET 30S, with a completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,922.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,670.56 and has a completion date of January 17, 2025. It is a Firm Fixed Price contract for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 firm-fixed-price delivery order is for the supply of FYCOMPA 8 MG TABLET 30S, a prescription medication. The award has no set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 4 MG TABLET 30S. The contract has a firm fixed price of $5,693.50 and a period of performance through April 1, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,731.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through November 27, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8TF
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,169.29 with a firm fixed price and an ultimate completion date of January 16, 2025. The contract is for the supply of FYCOMPA 2 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/21/25, 3:50 AM